FDA Reopens DTC Ad Rule Comment Period
Drugmakers have until Feb. 26 to submit additional comments on a proposed rule that establishes standards for the presentation of risk information in direct-to-consumer (DTC) television and radio advertisements.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.